glp 1 with ulcerative colitis drugs and GLP-1 Drugs: For Multiple Chronic Conditions Ozempic and ulcerative colitis: Possible
Description
doi: 10.1111/ijd.17246
GLP-1 meds slow digestion
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
The researchers determined breast cancer incidence as the primary study outcome
Of note, creatinine values can vary up to 0.6 mg/dL and still be considered within the normal range
